2023-02-022024-03-312024-03-31false14634832ASHINGTON HEALTHCARE LIMITED2024-10-30iso4217:GBPxbrli:pure146348322023-02-02146348322024-03-31146348322023-02-022024-03-31146348322023-02-01146348322023-02-01146348322023-02-012023-02-0114634832bus:SmallEntities2023-02-022024-03-3114634832bus:AuditExempt-NoAccountantsReport2023-02-022024-03-3114634832bus:FullAccounts2023-02-022024-03-3114634832bus:PrivateLimitedCompanyLtd2023-02-022024-03-3114634832core:WithinOneYear2024-03-3114634832core:AfterOneYear2024-03-3114634832core:WithinOneYear2023-02-0114634832core:AfterOneYear2023-02-0114634832core:ShareCapital2024-03-3114634832core:SharePremium2024-03-3114634832core:RevaluationReserve2024-03-3114634832core:OtherReservesSubtotal2024-03-3114634832core:RetainedEarningsAccumulatedLosses2024-03-3114634832core:ShareCapital2023-02-0114634832core:SharePremium2023-02-0114634832core:RevaluationReserve2023-02-0114634832core:OtherReservesSubtotal2023-02-0114634832core:RetainedEarningsAccumulatedLosses2023-02-0114634832core:LandBuildings2024-03-3114634832core:PlantMachinery2024-03-3114634832core:Vehicles2024-03-3114634832core:FurnitureFittings2024-03-3114634832core:OfficeEquipment2024-03-3114634832core:NetGoodwill2024-03-3114634832core:IntangibleAssetsOtherThanGoodwill2024-03-3114634832core:ListedExchangeTraded2024-03-3114634832core:UnlistedNon-exchangeTraded2024-03-3114634832core:LandBuildings2023-02-0114634832core:PlantMachinery2023-02-0114634832core:Vehicles2023-02-0114634832core:FurnitureFittings2023-02-0114634832core:OfficeEquipment2023-02-0114634832core:NetGoodwill2023-02-0114634832core:IntangibleAssetsOtherThanGoodwill2023-02-0114634832core:ListedExchangeTraded2023-02-0114634832core:UnlistedNon-exchangeTraded2023-02-0114634832core:LandBuildings2023-02-022024-03-3114634832core:PlantMachinery2023-02-022024-03-3114634832core:Vehicles2023-02-022024-03-3114634832core:FurnitureFittings2023-02-022024-03-3114634832core:OfficeEquipment2023-02-022024-03-3114634832core:NetGoodwill2023-02-022024-03-3114634832core:IntangibleAssetsOtherThanGoodwill2023-02-022024-03-3114634832core:ListedExchangeTraded2023-02-022024-03-3114634832core:UnlistedNon-exchangeTraded2023-02-022024-03-3114634832core:MoreThanFiveYears2023-02-022024-03-3114634832core:Non-currentFinancialInstruments2024-03-3114634832core:Non-currentFinancialInstruments2023-02-0114634832dpl:CostSales2023-02-022024-03-3114634832dpl:DistributionCosts2023-02-022024-03-3114634832core:LandBuildings2023-02-022024-03-3114634832core:PlantMachinery2023-02-022024-03-3114634832core:Vehicles2023-02-022024-03-3114634832core:FurnitureFittings2023-02-022024-03-3114634832core:OfficeEquipment2023-02-022024-03-3114634832dpl:AdministrativeExpenses2023-02-022024-03-3114634832core:NetGoodwill2023-02-022024-03-3114634832core:IntangibleAssetsOtherThanGoodwill2023-02-022024-03-3114634832dpl:GroupUndertakings2023-02-022024-03-3114634832dpl:ParticipatingInterests2023-02-022024-03-3114634832dpl:GroupUndertakingscore:ListedExchangeTraded2023-02-022024-03-3114634832core:ListedExchangeTraded2023-02-022024-03-3114634832dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-02-022024-03-3114634832core:UnlistedNon-exchangeTraded2023-02-022024-03-3114634832dpl:CostSales2023-02-012023-02-0114634832dpl:DistributionCosts2023-02-012023-02-0114634832core:LandBuildings2023-02-012023-02-0114634832core:PlantMachinery2023-02-012023-02-0114634832core:Vehicles2023-02-012023-02-0114634832core:FurnitureFittings2023-02-012023-02-0114634832core:OfficeEquipment2023-02-012023-02-0114634832dpl:AdministrativeExpenses2023-02-012023-02-0114634832core:NetGoodwill2023-02-012023-02-0114634832core:IntangibleAssetsOtherThanGoodwill2023-02-012023-02-0114634832dpl:GroupUndertakings2023-02-012023-02-0114634832dpl:ParticipatingInterests2023-02-012023-02-0114634832dpl:GroupUndertakingscore:ListedExchangeTraded2023-02-012023-02-0114634832core:ListedExchangeTraded2023-02-012023-02-0114634832dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-02-012023-02-0114634832core:UnlistedNon-exchangeTraded2023-02-012023-02-0114634832core:NetGoodwill2024-03-3114634832core:IntangibleAssetsOtherThanGoodwill2024-03-3114634832core:LandBuildings2024-03-3114634832core:PlantMachinery2024-03-3114634832core:Vehicles2024-03-3114634832core:FurnitureFittings2024-03-3114634832core:OfficeEquipment2024-03-3114634832core:AfterOneYear2024-03-3114634832core:WithinOneYear2024-03-3114634832core:ListedExchangeTraded2024-03-3114634832core:UnlistedNon-exchangeTraded2024-03-3114634832core:ShareCapital2024-03-3114634832core:SharePremium2024-03-3114634832core:RevaluationReserve2024-03-3114634832core:OtherReservesSubtotal2024-03-3114634832core:RetainedEarningsAccumulatedLosses2024-03-3114634832core:NetGoodwill2023-02-0114634832core:IntangibleAssetsOtherThanGoodwill2023-02-0114634832core:LandBuildings2023-02-0114634832core:PlantMachinery2023-02-0114634832core:Vehicles2023-02-0114634832core:FurnitureFittings2023-02-0114634832core:OfficeEquipment2023-02-0114634832core:AfterOneYear2023-02-0114634832core:WithinOneYear2023-02-0114634832core:ListedExchangeTraded2023-02-0114634832core:UnlistedNon-exchangeTraded2023-02-0114634832core:ShareCapital2023-02-0114634832core:SharePremium2023-02-0114634832core:RevaluationReserve2023-02-0114634832core:OtherReservesSubtotal2023-02-0114634832core:RetainedEarningsAccumulatedLosses2023-02-0114634832core:NetGoodwill2023-02-0114634832core:IntangibleAssetsOtherThanGoodwill2023-02-0114634832core:LandBuildings2023-02-0114634832core:PlantMachinery2023-02-0114634832core:Vehicles2023-02-0114634832core:FurnitureFittings2023-02-0114634832core:OfficeEquipment2023-02-0114634832core:AfterOneYear2023-02-0114634832core:WithinOneYear2023-02-0114634832core:ListedExchangeTraded2023-02-0114634832core:UnlistedNon-exchangeTraded2023-02-0114634832core:ShareCapital2023-02-0114634832core:SharePremium2023-02-0114634832core:RevaluationReserve2023-02-0114634832core:OtherReservesSubtotal2023-02-0114634832core:RetainedEarningsAccumulatedLosses2023-02-0114634832core:AfterOneYear2023-02-022024-03-3114634832core:WithinOneYear2023-02-022024-03-3114634832core:Non-currentFinancialInstrumentscore:CostValuation2023-02-022024-03-3114634832core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-02-022024-03-3114634832core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-02-022024-03-3114634832core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-02-022024-03-3114634832core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-02-022024-03-3114634832core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-02-022024-03-3114634832core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-02-022024-03-3114634832core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-02-022024-03-3114634832core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-02-022024-03-3114634832core:Non-currentFinancialInstrumentscore:CostValuation2024-03-3114634832core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-03-3114634832core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-03-3114634832core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-03-3114634832core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-03-3114634832core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-03-3114634832core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-03-3114634832core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-03-3114634832core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-03-3114634832core:Non-currentFinancialInstrumentscore:CostValuation2023-02-0114634832core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-02-0114634832core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-02-0114634832core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-02-0114634832core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-02-0114634832core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-02-0114634832core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-02-0114634832core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-02-0114634832core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-02-0114634832bus:Director12023-02-022024-03-3114634832bus:Director22023-02-022024-03-3114634832bus:Director32023-02-022024-03-3114634832bus:Director42023-02-022024-03-3114634832core:FurnitureFittingsToolsEquipment2023-02-022024-03-3114634832core:FurnitureFittingsToolsEquipment2024-03-3114634832core:FurnitureFittingsToolsEquipment2023-02-01

ASHINGTON HEALTHCARE LIMITED

Registered Number
14634832
(England and Wales)

Unaudited Financial Statements for the Period ended
31 March 2024

ASHINGTON HEALTHCARE LIMITED
Company Information
for the period from 2 February 2023 to 31 March 2024

Directors

BELL, Andrew David, Dr
CHOPRA, Rakesh
GILFILLAN, Lindsay John, Dr
KULLAR, Sukhpreet Singh

Registered Address

Lintonville Medical Group
Lintonville Terrace
Ashington
NE63 9UT

Registered Number

14634832 (England and Wales)
ASHINGTON HEALTHCARE LIMITED
Statement of Financial Position
31 March 2024

Notes

2024

£

£

Fixed assets
Intangible assets3184,909
Tangible assets421,139
206,048
Current assets
Stocks547,826
Debtors668,570
Cash at bank and on hand6,213
122,609
Creditors amounts falling due within one year7(369,836)
Net current assets (liabilities)(247,227)
Total assets less current liabilities(41,179)
Net assets(41,179)
Capital and reserves
Called up share capital105
Profit and loss account(41,284)
Shareholders' funds(41,179)
The financial statements were approved and authorised for issue by the Board of Directors on 30 October 2024, and are signed on its behalf by:
CHOPRA, Rakesh
Director
Registered Company No. 14634832
ASHINGTON HEALTHCARE LIMITED
Notes to the Financial Statements
for the period ended 31 March 2024

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Basis of preparation
The financial statements have been prepared under the historical cost convention on a going concern basis unless otherwise specified within these accounting policies and in accordance with Section 1A of Financial Reporting Standard 102, the Financial Reporting Standard applicable in the UK and the Republic of Ireland and the Companies Act 2006.
Functional and presentation currency
The financial statements are presented in sterling and this is the functional currency of the company.
Turnover policy
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and/or the rendering of services. Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have transferred to the buyer.
Operating leases
Where, substantially, all the risks and rewards of ownership of the asset do not transfer from the lessor to the company, the lease is treated as an operating lease. Rentals payable under operating leases are charged to the Income Statement on a straight-line basis over the period of the lease.
Defined contribution pension plan
The company operates a defined contribution plan for its employees. A defined contribution plan is a pension plan under which the company pays fixed contributions into a separate entity. Once the contributions have been paid the company has no further obligation. Contributions to defined contribution plans are expensed in the period to which they relate. Amounts not paid are shown in other creditors in the Statement of Financial Position. The assets of the plan are held separately from the company in independently administered funds.
Intangible assets
Intangible assets are stated at cost less accumulated amortisation and accumulated impairment losses. The assets are reviewed for impairment if the above factors indicate that the carrying amount may be impaired. Amortisation is included in 'administrative expenses' in the profit and loss account.
Amortisation
The goodwill is amortised over a period of 10 years on a straight line basis.
Tangible fixed assets and depreciation
Tangible fixed assets are stated at cost or valuation less depreciation. The assets residual values, useful lives and depreciation methods are reviewed and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date. Gains and losses on disposal are determined by comparing the proceeds with the carrying amount and are recognised in the Income Statement Depreciation is provided on all tangible fixed assets as follows:

Reducing balance (%)Straight line (years)
Fixtures and fittings15-
Vehicles25-
Office Equipment-3
Stocks and work in progress
Stocks are valued at the lower of cost and estimated selling price (less any associated costs to enable such sales to complete). At each date of Statement of Financial Position, stocks are assessed for impairment. If stock is impaired, the carrying amount is reduced to its selling price less costs to complete and sell. The impairment loss is recognised immediately in the Income Statement.
2.Average number of employees

2024
Average number of employees during the year5
3.Intangible assets

Goodwill

Total

££
Cost or valuation
Additions191,847191,847
At 31 March 24191,847191,847
Amortisation and impairment
Charge for year6,9386,938
At 31 March 246,9386,938
Net book value
At 31 March 24184,909184,909
At 01 February 23--
4.Tangible fixed assets

Land & buildings

Vehicles

Fixtures & fittings

Office Equipment

Total

£££££
Cost or valuation
Additions118,7501,7411,67722,169
At 31 March 24118,7501,7411,67722,169
Depreciation and impairment
Charge for year-7811091401,030
At 31 March 24-7811091401,030
Net book value
At 31 March 24117,9691,6321,53721,139
At 01 February 23-----
5.Stocks

2024

£
Other stocks47,826
Total47,826
6.Debtors: amounts due within one year

2024

£
Trade debtors / trade receivables50,339
Other debtors14,334
Prepayments and accrued income3,897
Total68,570
7.Creditors: amounts due within one year

2024

£
Trade creditors / trade payables80,615
Amounts owed to related parties279,375
Taxation and social security1,219
Other creditors277
Accrued liabilities and deferred income8,350
Total369,836
8.Operating lease commitments
At 31 March 2024 the company had future minimum lease payments under non-cancellable operating leases of £60,000.
9.Parent-subsidiary relationships
The company is a wholly owned subsidiary of Ashington Central Limited, a company registered in England and Wales. The parent company is exempt from preparing group accounts.